Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis.

Currently, standard treatment of metastatic prostatic cancer (MPCa) is androgen-deprivation therapy (ADT). Recent studies suggested that local treatment of MPCa is related to increase of survival of those patients, as observed in other tumors.